| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: SecondLook Health |
| Recipient: You |
|
| Honoraria |
| Company: Research to Practice CME |
| Recipient: You |
| Company: Medscape CME |
| Recipient: You |
| Company: Projects in Knowledge CME |
| Recipient: You |
| Company: MJH Life Sciences CME |
| Recipient: You |
| Company: PlatformQ/Medlive CME |
| Recipient: You |
| Company: IDEOlogy Health |
| Recipient: You |
| Company: Navya Network Inc |
| Recipient: You |
| Company: Curio Science |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: AstraZeneca |
| Recipient: You |
| Company: Genentech/Roche |
| Recipient: You |
| Company: Takeda Pharmaceuticals |
| Recipient: You |
| Company: Eli Lilly and Company |
| Recipient: You |
| Company: Amgen |
| Recipient: You |
| Company: Iovance Biotherapeutics |
| Recipient: You |
| Company: Regeneron Pharmaceuticals |
| Recipient: You |
| Company: Natera |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
| Company: Abbvie |
| Recipient: You |
| Company: Summit Therapeutics |
| Recipient: You |
| Company: Novartis |
| Recipient: You |
| Company: Novocure |
| Recipient: You |
| Company: Janssen Oncology |
| Recipient: You |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: Nuvation Bio |
| Recipient: You |
| Company: Boehringer Ingelheim |
| Recipient: You |
| Company: Daiichi Sankyo |
| Recipient: You |
| Company: GlaxoSmithKline |
| Recipient: You |
| Company: Oxford BioTherapeutics |
| Recipient: You |
| Company: Taiho Pharmaceutical |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Revolution Medicines |
| Recipient: You |
| Company: Nuvalent, Inc. |
| Recipient: You |
| Company: Genentech/Roche |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Boehringer Ingelheim |
| Recipient: Your Institution |
| Company: Exelixis |
| Recipient: Your Institution |
| Company: Takeda Pharmaceuticals |
| Recipient: Your Institution |
| Company: Adaptimmune |
| Recipient: Your Institution |
| Company: GSK |
| Recipient: Your Institution |
| Company: Janssen |
| Recipient: Your Institution |
| Company: Eli Lilly |
| Recipient: Your Institution |
| Company: Gilead Sciences |
| Recipient: Your Institution |
| Company: Taiho Pharmaceutical |
| Recipient: Your Institution |
| Company: BioNTech SE |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: Up To Date - Royalties |
| Recipient: You |
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|